Trade

Camlin Fine Sciences share price

High risk
  • 52%Low risk
  • 52%Moderate risk
  • 52%Balanced risk
  • 52%High risk
  • 52%Extreme risk
  • ₹162.50(12.50%)
    December 12, 2025 15:29:11 PM IST
    • NSE
    • BSE
  • Vol : 5.21 M (NSE + BSE)
    Last 20 day avg : 600.28 K

Camlin Fine Sciences is trading 12.50% upper at Rs 162.50 as compared to its last closing price. Camlin Fine Sciences has been trading in the price range of 170.00 & 144.70. Camlin Fine Sciences has given 13.80% in this year & -6.38% in the last 5 days. Camlin Fine Sciences has TTM P/E ratio 17.00 as compared to the sector P/E of 19.38.There are 2 analysts who have initiated coverage on Camlin Fine Sciences. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of -14.38 Crores in its last quarter.Listed peers of Camlin Fine Sciences include Pidilite Industries (0.73%), Asian Paints (-0.57%), SRF (2.76%).The Mutual Fund holding in Camlin Fine Sciences was at 7.04% in 30 Nov 2025. The MF holding has increased from the last quarter. The FII holding in Camlin Fine Sciences was at 2.14% in 30 Nov 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 13, 2025, 05:34 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.50
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.76
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    3.04
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
144.70
Highest
170.00
52 week range
Lowest
110.39
Highest
334.70
Camlin Fine Sciences News
Camlin Fine Sciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Pidilite Industries
Neutral
1,477.500.731,50,757.8072.0215.480.672.26
Asian Paints
Neutral
2,763.30-0.572,65,055.1372.2014.610.857.13
SRF
Bullish
3,023.502.7689,781.1967.086.670.2716.14
Coromandel International
Bullish
2,310.452.6967,838.5437.576.110.525.40
Solar Industries India
Bearish
12,303.65-1.191,11,188.0293.5526.70.089.52
Mutual Fund Ownership
View all
JM Small Cap Fund Regular Growth
NA
  • Amount Invested (Cr.) 18.62
  • % of AUM 2.58
JM Aggressive Hybrid Fund Growth
4/5
  • Amount Invested (Cr.) 18.98
  • % of AUM 2.31
ICICI Prudential Commodities Fund Regular Growth
NA
  • Amount Invested (Cr.) 36.24
  • % of AUM 1.32
ICICI Prudential Retirement Fund Pure Equity Plan Regular Growth
NA
  • Amount Invested (Cr.) 7.30
  • % of AUM 0.60
ICICI Prudential Dividend Yield Equity Fund Growth
NA
  • Amount Invested (Cr.) 5.78
  • % of AUM 0.11
Camlin Fine Sciences Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-10Quarterly Results
2025-09-29Preferential Issue of shares
2025-08-08Quarterly Results
2025-05-23Audited Results
2025-02-14Quarterly Results
About the company Camlin Fine Sciences
  • IndustryChemical Manufacturing
  • ISININE052I01032
  • BSE Code532834
  • NSE CodeCAMLINFINE
Camlin Fine Sciences Limited is an India-based company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company’s products are categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company’s products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosis.
  • Management Info
  • Ashish DandekarChairman of the Board, Managing Director
  • Santosh ParabChief Financial Officer
  • Nilesh JadhavChief Operating Officer
  • Rahul SawaleChief Compliance Officer, Vice President - Legal, Company Secretary
  • Nirmal MomayaManaging Director
  • Arjun DukaneExecutive Director - Technical
Camlin Fine Sciences Share Price FAQs

Camlin Fine Sciences is trading at 162.50 as on Fri Dec 12 2025 09:59:11. This is 12.50% upper as compared to its previous closing price of 144.45.

The market capitalization of Camlin Fine Sciences is 3029.52 Cr as on Fri Dec 12 2025 09:59:11.

The average broker rating on Camlin Fine Sciences is Hold. The breakup of analyst rating is given below -

  • 0.00 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Camlin Fine Sciences is 334.70 whereas the 52 wk low is 110.39

Camlin Fine Sciences can be analyzed on the following key metrics -

  • TTM P/E: 17.00
  • Sector P/E: 19.38
  • Dividend Yield: 0.00%
  • D/E ratio: 0.76

Camlin Fine Sciences reported a net profit of -139.05 Cr in 2025.

The Mutual Fund Shareholding was 7.04% at the end of 30 Nov 2025.

Quick Links
EQUITY QUICK LINKS
Camlin Fine Sciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Camlin Fine Sciences share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.